Latest news
Loading news…
IASO Biotherapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Nanjing, Jiangsu, China Founded 2017 101-250 employees For Profit
IASO Biotherapeutics is a biopharmaceutical company focused on the development of cell therapies in the field of oncology.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
11
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 10
Company Info
- Founded
- 2017
- Employees
- 101-250
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 33
- HQ
- Nanjing, Jiangsu, China
- Region
- Asia-Pacific (APAC)
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- 0
- Trend (90d)
- 2
- Last leadership hire
- Oct 19, 2021
Key People at IASO Biotherapeutics
CEO & CMO
Chief Technology Officer and Executive Vice President
Chief Scientific Officer
11
professional contacts at IASO Biotherapeutics
Contact execs at IASO Biotherapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to IASO Biotherapeutics
Loading news…
FAQs about IASO Biotherapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.